Background Globally COVID-19 has had a profound impact on the psychological wellbeing of millions of people, and there is an urgent imperative to address elevated levels of distress during the COVID-19 pandemic. The World Health Organization (WHO) has developed Problem Management Plus (PM+), a low intensity psychological intervention for adults experiencing psychological distress. This paper outlines the study protocol for a trial that tests the effectiveness of an adapted version of PM+ to reduce distress associated with COVID-19. Methods A single-blind, parallel, randomized controlled trial will be carried out for distressed people across Australia. via video conferencing on a small group basis. Following informed consent, adults that screen positive for levels of psychological distress (General Health Questionnaire-12 (GHQ-12 score ≥ 3) and have access to videoconferencing platform will be randomised to an adapted version of gPM+ ( n = 120) or enhanced treatment as usual (ETAU) (n = 120). The primary outcome will be reduction in psychological distress including anxiety and depression at 2-months post treatment. Secondary outcomes include worry, sleep problems, anhedonia, social support, and stress in relation to COVID-19. Discussion The trial aims assess whether an adapted version of videoconferencing PM+ that is specifically designed to target COVI-19 related distress will result in reduced distress relative to enhanced usual care. Trial registration This trial was prospectively registered on the ANZCTR on 14/4/20 ( ACTRN12620000468921 ).
【저자키워드】 COVID-19, Controlled trial, Psychosocial intervention, Psychological distress, 【초록키워드】 Randomized controlled trial, Treatment, Anxiety, Depression, Trial, Study protocol, randomised, Stress, COVID-19 pandemic, outcome, Effectiveness, Social support, Psychological distress, WHO, Informed consent, Psychological, platform, distress, Worry, Health Organization, post treatment, Support, World Health Organization, anhedonia, intensity, Psychological intervention, Primary outcome, Trial registration, problems, Secondary outcomes, usual care, Registered, single-blind, problem, positive, GHQ-12, videoconferencing, secondary, carried, include, elevated, reduced, imperative, reduce, reduction in, treatment as usual, with COVID-19, 【제목키워드】 Psychological intervention, reducing,